When Sens. Richard Blumenthal and Elizabeth Warren surveyed the nation’s pharmacies they found most of them failed to stock Lispro, a lower-cost insulin.
rebates
Posted inHealth
CT lawmakers hail U.S. House approval of prescription drug bill
The most controversial section of the bill would direct the secretary of the Department of Health and Human Services to directly negotiate with drugmakers on the price of medications covered under Medicare.
Posted inHealth
House unanimously passes bill to shine light on drug industry
The state House of Representatives unanimously approved a comprehensive bill that aims to shed light on the murky prescription drug industry, which state officials say is a necessary first step to lowering expensive drug costs.
Posted inHealth
Clock ticking on a bipartisan scramble to curb drug costs
With only two weeks left in the legislative session, a Democratic lawmaker and the state comptroller are feverishly working to bring to the House floor proposed legislation that is considered Connecticut’s most comprehensive effort so far to control high prescription drug costs.
Posted inHealth, Politics
Blumenthal says EpiPen maker gouged CT, wants the money back
Washington – A year after it was embroiled in scandal for jacking up the price of EpiPen injectors of a life saving anti-allergy medicine, the company that makes them is accused of overcharging state and federal governments, too, by $1.27 billion. Sen. Richard Blumenthal wants some of that money returned to Connecticut
Posted inMoney
ACA requires CT insurers to issue $3 million in rebates
WASHINGTON – Thousands of Connecticut residents will get rebate checks or other types of credit from their health insurance companies. They are getting those refunds because the federal government says they paid too much for coverage.